RG
Redmile Group’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41M | Hold |
441,701
| – | – | 0.36% | 37 |
|
|
2025
Q1 | $2.62M | Hold |
441,701
| – | – | 0.25% | 47 |
|
|
2024
Q4 | $5.88M | Sell |
441,701
-10,569
| -2% | -$141K | 0.41% | 45 |
|
|
2024
Q3 | $3.68M | Hold |
452,270
| – | – | 0.22% | 49 |
|
|
2024
Q2 | $3.84M | Sell |
452,270
-8,811,039
| -95% | -$74.9M | 0.23% | 49 |
|
|
2024
Q1 | $6.43M | Buy |
9,263,309
+156,863
| +2% | +$109K | 0.24% | 65 |
|
|
2023
Q4 | $4.67M | Buy |
9,106,446
+2,825,633
| +45% | +$1.45M | 0.17% | 57 |
|
|
2023
Q3 | $9.3M | Buy |
6,280,813
+232,690
| +4% | +$344K | 0.44% | 45 |
|
|
2023
Q2 | $9.74M | Buy |
6,048,123
+436,067
| +8% | +$702K | 0.37% | 49 |
|
|
2023
Q1 | $16.3M | Sell |
5,612,056
-630,700
| -10% | -$1.83M | 0.71% | 45 |
|
|
2022
Q4 | $20.5M | Hold |
6,242,756
| – | – | 0.84% | 35 |
|
|
2022
Q3 | $23.6M | Hold |
6,242,756
| – | – | 0.92% | 35 |
|
|
2022
Q2 | $48.6M | Sell |
6,242,756
-3,155
| -0.1% | -$24.6K | 1.86% | 18 |
|
|
2022
Q1 | $58M | Sell |
6,245,911
-191,866
| -3% | -$1.78M | 1.81% | 17 |
|
|
2021
Q4 | $101M | Sell |
6,437,777
-28,500
| -0.4% | -$449K | 2.31% | 12 |
|
|
2021
Q3 | $116M | Buy |
6,466,277
+16,700
| +0.3% | +$299K | 2.02% | 16 |
|
|
2021
Q2 | $100M | Sell |
6,449,577
-435,656
| -6% | -$6.77M | 1.48% | 21 |
|
|
2021
Q1 | $98.9M | Buy |
6,885,233
+22,163
| +0.3% | +$318K | 1.39% | 22 |
|
|
2020
Q4 | $135M | Sell |
6,863,070
-75,800
| -1% | -$1.49M | 1.63% | 19 |
|
|
2020
Q3 | $89.9M | Buy |
6,938,870
+95,500
| +1% | +$1.24M | 1.65% | 16 |
|
|
2020
Q2 | $99.7M | Buy |
6,843,370
+1,550,000
| +29% | +$22.6M | 1.84% | 15 |
|
|
2020
Q1 | $45M | Buy |
5,293,370
+644,800
| +14% | +$5.49M | 1.26% | 29 |
|
|
2019
Q4 | $76.6M | Buy |
4,648,570
+128,853
| +3% | +$2.12M | 1.83% | 18 |
|
|
2019
Q3 | $63.8M | Sell |
4,519,717
-81,200
| -2% | -$1.15M | 2.14% | 16 |
|
|
2019
Q2 | $92.5M | Buy |
4,600,917
+115,500
| +3% | +$2.32M | 2.62% | 10 |
|
|
2019
Q1 | $178M | Buy |
4,485,417
+70,800
| +2% | +$2.81M | 5.22% | 4 |
|
|
2018
Q4 | $153M | Buy |
4,414,617
+195,900
| +5% | +$6.81M | 6.17% | 2 |
|
|
2018
Q3 | $174M | Buy |
4,218,717
+92,100
| +2% | +$3.81M | 5.37% | 2 |
|
|
2018
Q2 | $152M | Sell |
4,126,617
-109,400
| -3% | -$4.02M | 5.15% | 3 |
|
|
2018
Q1 | $165M | Buy |
4,236,017
+1,420,029
| +50% | +$55.4M | 6.38% | 2 |
|
|
2017
Q4 | $51M | Sell |
2,815,988
-73,722
| -3% | -$1.33M | 2.22% | 15 |
|
|
2017
Q3 | $47.8M | Buy |
2,889,710
+155,666
| +6% | +$2.58M | 2.36% | 13 |
|
|
2017
Q2 | $38.3M | Sell |
2,734,044
-74
| -0% | -$1.04K | 2.33% | 12 |
|
|
2017
Q1 | $56.2M | Buy |
2,734,118
+63,176
| +2% | +$1.3M | 3.65% | 6 |
|
|
2016
Q4 | $37.9M | Buy |
2,670,942
+649,325
| +32% | +$9.22M | 3.27% | 11 |
|
|
2016
Q3 | $43.2M | Sell |
2,021,617
-387,353
| -16% | -$8.29M | 3.44% | 11 |
|
|
2016
Q2 | $54.2M | Buy |
2,408,970
+133,205
| +6% | +$3M | 5.18% | 5 |
|
|
2016
Q1 | $43.3M | Buy |
2,275,765
+740,803
| +48% | +$14.1M | 4.43% | 7 |
|
|
2015
Q4 | $40.5M | Buy |
1,534,962
+485,180
| +46% | +$12.8M | 3.03% | 14 |
|
|
2015
Q3 | $33M | Buy |
1,049,782
+677,140
| +182% | +$21.3M | 2.5% | 17 |
|
|
2015
Q2 | $19.7M | Buy |
372,642
+107,437
| +41% | +$5.67M | 1.61% | 24 |
|
|
2015
Q1 | $11M | Buy |
265,205
+939
| +0.4% | +$39K | 0.99% | 36 |
|
|
2014
Q4 | $7.07M | Buy |
+264,266
| New | +$7.07M | 0.77% | 38 |
|